ExodusPoint Capital Management, LP - RECURSION PHARMACEUTICALS IN ownership

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 158 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.9%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of RECURSION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$208
-100.0%
31,137
-32.1%
0.00%
-66.7%
Q3 2022$488,000
-68.8%
45,832
-76.1%
0.01%
-68.4%
Q2 2022$1,563,000
+548.5%
192,073
+469.7%
0.02%
+533.3%
Q1 2022$241,00033,7130.00%
Other shareholders
RECURSION PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
Kinnevik AB (publ) 10,405,668$77,730,340100.00%
Data Collective IV GP, LLC 5,941,120$44,380,16632.86%
MV Management XI, L.L.C. 1,971,908$14,730,15325.77%
MIC Capital Management UK LLP 8,451,758$63,134,63512.84%
Yong Rong (HK) Asset Management Ltd 1,174,200$8,7723.85%
ArchPoint Investors 1,114,626$8,326,2563.22%
PLATINUM INVESTMENT MANAGEMENT LTD 2,711,148$20,252,2760.70%
HARVARD MANAGEMENT CO INC 882,129$6,5900.65%
Diametric Capital, LP 119,906$895,6980.40%
Lingotto Investment Management LLP 775,077$5,789,8250.37%
View complete list of RECURSION PHARMACEUTICALS IN shareholders